Inovio Pharma (INO) Misses Q4 EPS by $1.13
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.14 +4.59%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($1.45), $1.13 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $2.84 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
